STADA Arzneimittel Aktiengesellschaft (STDAF) Short Interest Ratio & Short Volume

Short interest is the volume of STADA Arzneimittel Aktiengesellschaft shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 100 shares of STDAF short. Learn More on STADA Arzneimittel Aktiengesellschaft's current short interest.

Here is how the short interest of companies in the sector of "medical" compare to STADA Arzneimittel Aktiengesellschaft: Exelixis, Inc. (3.01%), Jazz Pharmaceuticals plc (6.14%), Cytokinetics, Incorporated (13.91%), HealthEquity, Inc. (3.52%), Globus Medical, Inc. (5.55%), The Ensign Group, Inc. (5.93%), Inspire Medical Systems, Inc. (7.62%), Masimo Co. (8.28%), Elanco Animal Health Incorporated (3.14%), Vaxcyte, Inc. (7.58%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.67 billion), Match Group, Inc. ($3.64 billion), Wayfair Inc. ($3.47 billion), Tesla, Inc. ($3.00 billion), Ecolab Inc. ($2.97 billion), Morgan Stanley ($2.93 billion), The Charles Schwab Co. ($2.70 billion), Carnival Co. & plc ($2.38 billion), The Clorox Company ($2.29 billion), and Aon plc ($2.24 billion). View all of the most shorted stocks.

Short selling STDAF is an investing strategy that aims to generate trading profit from STADA Arzneimittel Aktiengesellschaft as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for STADA Arzneimittel Aktiengesellschaft occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of STDAF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STDAF, twice per month. The most recent reporting period available is June, 15 2020.